Ausgabe 6/2009
Inhalt (13 Artikel)
The fungal secondary metabolite trichodimerol inhibits TGF-β dependent cellular effects and tube formation of MDA-MB-231 cells
Annegret Serwe, Timm Anke, Gerhard Erkel
Regression of Dalton’s lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand
Raj K. Koiri, Surendra K. Trigun, Lallan Mishra, Kiran Pandey, Deobrat Dixit, Santosh K. Dubey
Boldine: a potential new antiproliferative drug against glioma cell lines
Daniéli Gerhardt, Ana Paula Horn, Mariana Maier Gaelzer, Rudimar Luiz Frozza, Andrés Delgado-Cañedo, Alessandra Luiza Pelegrini, Amélia T. Henriques, Guido Lenz, Christianne Salbego
Inhibitory effect of tea polyphenols on hepatic preneoplastic foci in Wistar rats
Smita Srivastava, Madhulika Singh, Preeti Roy, Sahdeo Prasad, Jasmine George, Yogeshwer Shukla
Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study
S. B. Benaka Prasad, K. Vinaya, C. S. Ananda Kumar, Sanjay Swarup, K. S. Rangappa
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis
Ansgar Brüning, Petra Burger, Marianne Vogel, Martina Rahmeh, Klaus Friese, Miriam Lenhard, Alexander Burges
“Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents
Nicolas Penel, Nicolas Isambert, Pierre Leblond, Charles Ferte, Alain Duhamel, Jacques Bonneterre
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol
Clovis O. Da Fonseca, Julio Thome Silva, Igor Rodrigo Lins, Marcela Simão, Adriano Arnobio, Débora Futuro, Thereza Quirico-Santos
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen
Lida Mina, Ian Krop, Robin T. Zon, Steven J. Isakoff, Charles J. Schneider, Menggang Yu, Cindy Johnson, LaTrice G. Vaughn, Yanping Wang, Maria Hristova-Kazmierski, Oluwatoyin O. Shonukan, George W. Sledge, Kathy D. Miller
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer
Bryan J. Schneider, Francis P. Worden, Shirish M. Gadgeel, Ralph E. Parchment, Collette M. Hodges, James Zwiebel, Rodney L. Dunn, Antoinette J. Wozniak, Michael J. Kraut, Gregory P. Kalemkerian
Trastuzumab-induced CCL20 and interleukin-8 mRNA in human whole blood ex vivo
Setsuo Hasegawa, Hideaki Kato, Hiroki Yamaguchi, Masafumi Yohda, Kazuhiko Obara, Hiroshi Izutsu, Mieko Ogura, Masato Mitsuhashi
Wound healing delay after central venous access following DCF/VEGF-trap therapy
Charles Ferté, Christophe Massard, Christian Moldovan, Eric Desruennes, Yohann Loriot, Jean-Charles Soria
Cyclin-dependent kinase inhibitors as potential targeted anticancer agents
Ivan Diaz-Padilla, Lillian L. Siu, Ignacio Duran